Publication dates

Growth Hormone Industry, November 2014 Market Reports from Top Publishers

You might be interested in: Protein, Drug Delivery, Biosimilar, more »


 
1-10 of 37 reports for Growth Hormone

SciGen Limited (Symbol:SIE) SWOT Analysis, Strategy, Revenues and Profits

SciGen Limited (Symbol:SIE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Recombinant human health care biotechnology derived products. Its products include recombinant human growth hormone, second generation recombinant human insulin, and recombinant human granulocyte ...

Biomm S.A. (Symbol:BIOM4) SWOT Analysis, Strategy, Revenues and Profits

Biomm S.A. (Symbol:BIOM4) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Insulin and other recombinant proteins. Its technology is used in the production of therapeutic proteins, such as calcitonin, interferons and growth hormones. The company offers processes for the production ...

China Recombinant Protein Drug Industry Report, 2014-2017

China Recombinant Protein Drug Industry Report, 2014-2017

  • $ 2 500
  • Industry report
  • November 2014
  • by Research In China

... Stimulating factor (rhg-csf)2.2.5Recombinant human growth hormone (rhgh)2.2.6 Recombinant human follicle-stimulating hormone (rhfsh)2.3 Market in china2.3.1 Market size2.3.2 Competition pattern ...

Bio Products Markets in China

Bio Products Markets in China

  • $ 4 000
  • Industry report
  • November 2014
  • by Asia Market Information & Development Company

... growth hormones production, demand and foreign traderecombinant human growth hormones output and demandrecombinant human growth hormones major producer and their market share ...

Pen Needles Market by Type (Standard and Safety), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, and 12mm), Therapy (Insulin, Glucagon-like peptide, Growth Hormones) - Analysis & Global Forecast to 2019

Pen Needles Market by Type (Standard and Safety), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, and 12mm), Therapy (Insulin, Glucagon-like peptide, Growth Hormones) - Analysis & Global Forecast to 2019

  • $ 4 650
  • Industry report
  • October 2014
  • by MarketsandMarkets

... And 12mm), therapy (insulin, glucagon-like peptide, growth hormones) - analysis & global forecast to 2019 table of contents1 introduction 151.1 Objectives of the study 151.2 Market scope ...

Growth Hormone Deficiency - Pipeline Review, H2 2014

Growth Hormone Deficiency - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • August 2014
  • by Global Markets Direct

... Stages of development ranging from pre-registration till discovery and undisclosed stages- a detailed assessment of monotherapy and combination therapy pipeline projects- coverage of the growth ...

Global Markets for Bioengineered Protein Drugs

Global Markets for Bioengineered Protein Drugs

  • $ 6 650
  • Industry report
  • August 2014
  • by BCC Research

... And fertility disorders, by region, through2019 ($ millions)132table 45 market share for bioengineered protein drugs by application ingrowth hormone, enzyme and fertility disorders, by region ...

 Growth Hormone Deficiency-Pipeline Insights, 2014

Growth Hormone Deficiency-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under growth hormone deficiency. This report provides information ...

Phage Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Phage Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... On protein products division manufactures and sells recombinant protein pharmaceuticals. Its nasal delivery of protein products consist of nasal growth hormone, nasal beta interferon, nasal g-csf and nasal pth ...

Asterion Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Asterion Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Of chronic and acute disorders. Its products include growth hormone agonists, erythropoietin, and granulocyte colony stimulating factor. Asterion uses profuse technology platform to engineer proteins for human ...

About 700 reports for Growth Hormone

Download Unlimited Documents from Trusted Public Sources

Novo Nordisk Annual Report 2013

  • Business Strategy
  • January 2013
    116 pages
  • Diabete  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.